Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits
Activating transcription factor 6 (ATF6) is located within the region of linkage to type 2 diabetes on chromosome 1q21-q23 and is a key activator of the endoplasmic reticulum stress response. We evaluated 78 single nucleotide polymorphisms (SNPs) spanning >213 kb in 95 people, from which we s...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2007
|
| _version_ | 1797072315981234176 |
|---|---|
| author | Chu, W Das, S Wang, H Chan, J Deloukas, P Froguel, P Baier, L Jia, W McCarthy, M Ng, M Damcott, C Shuldiner, A Zeggini, E Elbein, S |
| author_facet | Chu, W Das, S Wang, H Chan, J Deloukas, P Froguel, P Baier, L Jia, W McCarthy, M Ng, M Damcott, C Shuldiner, A Zeggini, E Elbein, S |
| author_sort | Chu, W |
| collection | OXFORD |
| description | Activating transcription factor 6 (ATF6) is located within the region of linkage to type 2 diabetes on chromosome 1q21-q23 and is a key activator of the endoplasmic reticulum stress response. We evaluated 78 single nucleotide polymorphisms (SNPs) spanning >213 kb in 95 people, from which we selected 64 SNPs for evaluation in 191 Caucasian case subjects from Utah and between 165 and 188 control subjects. Six SNPs showed nominal associations with type 2 diabetes (P = 0.001-0.04), including the nonsynonymous SNP rs1058405 (M67V) in exon 3 and rs11579627 in the 3′ flanking region. Only rs1159627 remained significant on permutation testing. The associations were not replicated in 353 African-American case subjects and 182 control subjects, nor were ATF6 SNPs associated with altered insulin secretion or insulin sensitivity in nondiabetic Caucasian individuals. No association with type 2 diabetes was found in a subset of 44 SNPs in Caucasian (n = 2,099), Pima Indian (n = 293), and Chinese (n = 287) samples. Allelic expression imbalance was found in transformed lymphocyte cDNA for 3′ untranslated region variants, thus suggesting cis-acting regulatory variants. ATF6 does not appear to play a major role in type 2 diabetes, but further work is required to identify the cause of the allelic expression imbalance. © 2007 by the American Diabetes Association. |
| first_indexed | 2024-03-06T23:06:01Z |
| format | Journal article |
| id | oxford-uuid:63d1fc53-4dca-421d-8b36-30320864b996 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:06:01Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:63d1fc53-4dca-421d-8b36-30320864b9962022-03-26T18:15:28ZActivating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traitsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:63d1fc53-4dca-421d-8b36-30320864b996EnglishSymplectic Elements at Oxford2007Chu, WDas, SWang, HChan, JDeloukas, PFroguel, PBaier, LJia, WMcCarthy, MNg, MDamcott, CShuldiner, AZeggini, EElbein, SActivating transcription factor 6 (ATF6) is located within the region of linkage to type 2 diabetes on chromosome 1q21-q23 and is a key activator of the endoplasmic reticulum stress response. We evaluated 78 single nucleotide polymorphisms (SNPs) spanning >213 kb in 95 people, from which we selected 64 SNPs for evaluation in 191 Caucasian case subjects from Utah and between 165 and 188 control subjects. Six SNPs showed nominal associations with type 2 diabetes (P = 0.001-0.04), including the nonsynonymous SNP rs1058405 (M67V) in exon 3 and rs11579627 in the 3′ flanking region. Only rs1159627 remained significant on permutation testing. The associations were not replicated in 353 African-American case subjects and 182 control subjects, nor were ATF6 SNPs associated with altered insulin secretion or insulin sensitivity in nondiabetic Caucasian individuals. No association with type 2 diabetes was found in a subset of 44 SNPs in Caucasian (n = 2,099), Pima Indian (n = 293), and Chinese (n = 287) samples. Allelic expression imbalance was found in transformed lymphocyte cDNA for 3′ untranslated region variants, thus suggesting cis-acting regulatory variants. ATF6 does not appear to play a major role in type 2 diabetes, but further work is required to identify the cause of the allelic expression imbalance. © 2007 by the American Diabetes Association. |
| spellingShingle | Chu, W Das, S Wang, H Chan, J Deloukas, P Froguel, P Baier, L Jia, W McCarthy, M Ng, M Damcott, C Shuldiner, A Zeggini, E Elbein, S Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits |
| title | Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits |
| title_full | Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits |
| title_fullStr | Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits |
| title_full_unstemmed | Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits |
| title_short | Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits |
| title_sort | activating transcription factor 6 atf6 sequence polymorphisms in type 2 diabetes and pre diabetic traits |
| work_keys_str_mv | AT chuw activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT dass activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT wangh activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT chanj activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT deloukasp activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT froguelp activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT baierl activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT jiaw activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT mccarthym activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT ngm activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT damcottc activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT shuldinera activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT zegginie activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits AT elbeins activatingtranscriptionfactor6atf6sequencepolymorphismsintype2diabetesandprediabetictraits |